A carregar...
HER2 Overexpression in Retinoblastoma: A Potential Therapeutic Target?
BACKGROUND: Retinoblastoma (RB) is the most common primary intraocular malignancy. Current therapies are associated with high morbidity in the short- and long-term. Human epidermal growth factor receptor 2 (HER2) is a transmembrane protein detected in 15–30% of breast cancers, but it has also been d...
Na minha lista:
| Publicado no: | Ocul Oncol Pathol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649335/ https://ncbi.nlm.nih.gov/pubmed/29230390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000455871 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|